Mayne Pharma (MAYNF, $2.54) lost -2 over the last three months. By comparison, the broader Pharmaceuticals: Major Industry returned 1 over the same period. A.I.dvisor analyzed 58 stocks in the Pharmaceuticals: Major Industry over the last three months, and found that of them (7) exhibited an Uptrend while of them (2) experienced a Downtrend.